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LETTER TO THE EDITOR
Zinc Level and Prevalence of Rejection in  
Transplanted Patients 
 
 
Dear Editor, 
High zinc level by promoting the immune system 
may cause rejection in the allograft organ. So it seems 
that limitation of zinc supplement and all foods and 
drugs with high amount of zinc may be effective in 
prevention of rejection after transplantation.  
Zinc is an essential micronutrient for human 
growth, development and immune function. 
Zinc deficiency was accompanied by the qualities 
and functional insufficiency of T-cell mediated im-
munity and by the diminished phagocytic activity of 
neutrophils.
1 
Kabu et al. in July 2006 revealed that zinc was in-
volved in multiple step of FC epsilon RI-induced 
mast cell activation and required for degranulation of 
cytokines such as IL-6 and TNF-α production and 
lymphocytes proliferation.
1,2 
In study by Chen et al. (Nov 2005) on the effects 
of different levels of zinc nutrition status on the im-
mune function of mice spleen lymphocytes showed 
that zinc status affected the immune function and 
production of IL-2 in spleen lymphocytes.
3 Rejection 
is one of the most important problems after organ 
transplantation. Immune system has a critical  role in 
this process .In the context of allograft rejection, T 
cells play a central role in the immune response, once 
activated, they secrete cytokines and chemokines to 
activate and attract cells such as CD8 T cells and 
macrophages into the allograft. They also interact 
with B cells that secrete alloreactive antibodies that 
eventually lead to allograft destruction.
4 
Moreover transplant rejection has both cellular 
and humeral components, some of the cytokines pro-
duced by T cells and macrophages (TNF-α) may me-
diate apoptosis of graft cells.
5 According to all those 
facts, it could be hypothesized that high zinc level by 
promoting the immune system may cause rejection in 
the allograft organ. 
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